Ramipril Recall: Check Your Blood Pressure Pills for This Manufacturer

This article contains affiliate links. If you purchase through one of these links, we may earn a commission at no extra cost to you. We only recommend products we believe in based on our own research and testing.

What Was Recalled

If you take ramipril for high blood pressure, you’ll want to check your prescription bottle today.

Hikma Pharmaceuticals USA Inc. has recalled a batch of Ramipril Capsules USP, 10 mg. The recall is nationwide within the United States.

The FDA recall number is D-0831-2026. Hikma initiated the recall voluntarily, with a recall initiation date of August 24, 2026, and an FDA report date of September 2, 2026.

Some news outlets covering this recall have reported a figure of more than 28,000 bottles affected. That number comes from press reporting on the recall, not from the FDA’s own enforcement record, so treat it as an estimate rather than a confirmed count.

Why It Matters

The reason for the recall is that the capsules failed impurities and degradation specifications.

In plain terms, testing found the medication had broken down, or contained impurity levels, outside of what the FDA allows. That’s a quality and stability problem with the pills themselves.

The FDA has classified this as a Class II recall. That means the recalled product could cause temporary or medically reversible health problems, or that the chance of serious harm is remote — it is a real safety concern, but not the FDA’s most severe classification.

Ramipril is an ACE-inhibitor medication used by a huge number of adults to manage blood pressure and protect the heart and kidneys. Impurity-related recalls in blood pressure medications have made headlines before, which is part of why this one is getting attention.

What To Do

Go find your ramipril prescription bottle right now.

Check three things: the drug name (Ramipril Capsules, 10 mg), the manufacturer (Hikma Pharmaceuticals USA Inc.), and the strength. If all three match, you likely have a recalled product.

Do not stop taking your blood pressure medication on your own. Suddenly stopping an ACE-inhibitor like ramipril without medical guidance can cause your blood pressure to spike, which carries its own risks.

Instead, call your pharmacist or prescribing doctor. Tell them about the recall and ask about a replacement prescription or an alternative medication while this is sorted out.

You can also verify the recall details yourself using the FDA’s official enforcement report for this recall: FDA Enforcement Report D-0831-2026.

Medication recalls like this one aren’t rare — we also covered a recent nationwide IV medication recall from Centric Compounding over sterility concerns, if you want to see how that one played out for patients.

FAQ

How do I know if I have the recalled bottle?

Look for “Ramipril Capsules USP, 10 mg” manufactured by Hikma Pharmaceuticals USA Inc. on your prescription label. If your bottle shows a different manufacturer or a different strength, it isn’t part of this recall. When in doubt, your pharmacy can check the lot against Hikma’s recall notice.

Is it dangerous?

The FDA classified this as a Class II recall, meaning the risk is generally temporary or reversible rather than life-threatening, though the agency still takes the issue seriously enough to require a nationwide recall. The concern here is that the capsules failed impurity and degradation testing, not that they were mislabeled with the wrong drug.

What do I do?

Check your bottle against the manufacturer and strength above, then contact your pharmacist or doctor to arrange a replacement. Don’t just toss the medication and go without treatment — get a replacement lined up first.

Should I stop taking it immediately?

Don’t stop cold turkey on your own. Talk to your pharmacist or doctor first about switching to a replacement supply, since abruptly discontinuing a blood pressure medication can itself be risky.